1Folkman J. Isolation of a tumor factor responsible to angiogenesis. J Exp Med, 1971, 133:275
2Dhar DK, Ono T, Yamanoi A,et al. Serum endostatin predicts tumorvascularity in hepatocellular carcinoma. Cancer, 2002, 95:2188
3McKenna GJ, Chen Y, Smith RM,et al. A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas. Am J Surg, 2002, 183:588
4Giannelli G, Bergamini C, Marinosci F,et al. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma. Int J Cancer, 2002, 97:425
5Lin SM, Lin CJ, Hsu CW,et al. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer, 2004, 100:376
6Damdinsuren B, Nagano H, Sakon M,et al. Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs. Ann Surg Oncol, 2003, 10:1184
7Wang L, Wu WZ, Sun HC,et al. Mechanism of interferon alpha on inhibition of metastasis and angiogenesis of hepatocellular carcinoma after curative resection in nude mice. J Gastrointest Surg, 2003, 7:587
8Kinoshita S, Hirai R, Yamano T,et al. Angiogenesis inhibitor TNP-470 can suppress hepatocellular carcinoma growth without retarding liver regeneration after partial hepatectomy. Surg Today, 2004, 34:40
9Kin M, Torimura T, Ueno T,et al. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats. Int J Oncol, 2000, 16:375
3Kan Z, Lvancev K, Lunderquist A, et al. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology, 1993, 187:621
